| __timestamp | PTC Therapeutics, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 396000000 |
| Thursday, January 1, 2015 | 121816000 | 364000000 |
| Friday, January 1, 2016 | 117633000 | 376000000 |
| Sunday, January 1, 2017 | 117456000 | 382000000 |
| Monday, January 1, 2018 | 171984000 | 432000000 |
| Tuesday, January 1, 2019 | 257452000 | 457000000 |
| Wednesday, January 1, 2020 | 477643000 | 463000000 |
| Friday, January 1, 2021 | 540684000 | 508000000 |
| Saturday, January 1, 2022 | 651496000 | 539000000 |
| Sunday, January 1, 2023 | 666563000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of pharmaceutical research, the investment in Research and Development (R&D) is a critical indicator of a company's commitment to innovation. Over the past decade, Zoetis Inc. and PTC Therapeutics, Inc. have demonstrated contrasting strategies in their R&D expenditures. From 2014 to 2023, PTC Therapeutics, Inc. increased its R&D spending by over 730%, peaking at approximately $667 million in 2023. This aggressive investment reflects their focus on pioneering treatments in genetic disorders. Meanwhile, Zoetis Inc., a leader in animal health, maintained a steady growth in R&D, with a 55% increase over the same period, reaching around $614 million in 2023. This consistent investment underscores their strategy of incremental innovation in veterinary medicine. As these companies continue to invest in R&D, their trajectories offer valuable insights into the future of pharmaceutical advancements.
R&D Spending Showdown: Eli Lilly and Company vs PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Pfizer Inc. and PTC Therapeutics, Inc.
R&D Insights: How Zoetis Inc. and Neurocrine Biosciences, Inc. Allocate Funds
R&D Insights: How Zoetis Inc. and Blueprint Medicines Corporation Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Evotec SE
Research and Development Investment: Pharming Group N.V. vs PTC Therapeutics, Inc.
R&D Spending Showdown: PTC Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for PTC Therapeutics, Inc. and Bausch Health Companies Inc.
PTC Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
PTC Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending